OECD sees a gradual and uneven global recovery over the next two years
„Policy still has a lot to do. If public health or fiscal policy falter then we would see a loss of confidence and a much more depressing outlook.“
As per the usual, take these forecasts with a pinch of salt as they are merely

Pfizer vaccine can be in use in the EU by the year-end if cleared
Pfizer-BioNTech just announced that they have submitted an application to the EMA today to seek clearance for coronavirus vaccine use in the EU.

Latest data released by Eurostat – 1 December 2020

Moderna reaffirms that its vaccine is 94.1% effective in primary analysis
– Vaccine was 94.1% effective in analysis of Phase 3 study, after 196 virus cases
– Vaccine was 100% effective against severe virus cases in trial

Some Brexit remarks by the European Commission
– People, businesses have had time to prepare for end of transition period
– If no-deal contingency plans are needed, they would be limited and adopted in time for 1 January
Some token remarks really, once again not giving anything away with regards to how the state of negotiations are playing

Comments by ECB president, Christine Lagarde
– Fiscal policy is critically important when services sector gets hit
– Fiscal and monetary policy coordination has helped a great deal
So far, she’s mainly speaking about how they have responded to the virus crisis since March. There’s no mention yet about any future policy steps ahead of next month.

Barnier just told reporters „there are reasons for determination“
Not really giving anything away, similar to the tone over the weekend. Talks are now continuing again between Barnier’s team and Frost’s team in London, so we’ll have to wait and see if there will be anything substantial later in the day.

Lagarde discusses the response to the pandemic

So report the Financial Times, saying the drug regulator in the country is . (FT may be gated.)  
The UK’s Medicines and Healthcare Products Regulatory Agency has the power to temporarily authorise products, in cases of urgent public need, thus bypassing the normal approval required from the European Medicines Agency (what this means is that while the

The UK Times reports over the weekend that the Commission has begun to „lean on“ EU negotiator Michel Barnier to get a trade deal with the UK. 
The but? Reuters cite an unnamed British source saying there is no call currently scheduled.